| 产品详情 |
| Edit |   |
|---|
| Product Name | SARS, Spike Protein, Middle, Recombinant |
|---|
| Description | Purity ~95% pure (10% PAGE Coomassie staining). GS-4B Sepharose Affinity Purification. Contains a mosaic of the immunodominant regions of themiddle region of the Spike protein. Not full-length spike protein. Contains GST fusion partner. Immunoreactive with SARS positive sera. A novel coronavirus has been identified as the causative agent of SARS (Severe Acute Respiratory Syndrome). Coronaviruses are a major cause of upper respiratory diseases in humans. The genomes of these viruses are positive stranded RNA approximately 27 to 31kb in length. SARS infection can be mediated by the binding of the viral spike protein, a glycosylated 139kD protein and the major surface antigen of the virus, to the angiotensin converting enzyme 2 (ACE2) on target cells. Source: E. coli Molecular Weight: ~38kD. May appear as multiple bands on SDS-PAGE (intact protein at 35kD, GST fusion protein at 26kD, and the Spike fragment at 12kD). Applications: Suitable for use in ELISA and Western Blot. |
|---|
| Size | 1mg |
|---|
| Concentration | n/a |
|---|
| Applications | ELISA WB |
|---|
| Other Names | SARS, Spike Protein, Middle, Recombinant (Severe Acute Respiratory Syndrome, SARS-CoV, SARS Associated Coronavirus) |
|---|
| Gene, Accession, CAS # | n/a |
|---|
| Catalog # | S0098-17G |
|---|
| Price | |
|---|
| Order / More Info | SARS, Spike Protein, Middle, Recombinant from UNITED STATES BIOLOGICAL |
|---|
| Product Specific References | n/a |
|---|
| 产品资料 |
|
|